Opening book details…
About this Medicine article
POS1042 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITOR, COMPARED WITH PLACEBO AND APREMILAST IN MODERATE TO SEVERE PLAQUE PSORIASIS: RESULTS FROM THE PHASE 3 POETYK PSO-1 STUDY by Armstrong, A. (author);Gooderham, M. (author);Warren, R.B. (author);Papp, K. (author);Strober, B. (author);Thaçi, D. (author);Colston, E. (author);Throup, J. (author);Kundu, S. (author);Banerjee, S. (author);Blauvelt, A. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Armstrong, A. (author);Gooderham, M. (author);Warren, R.B. (author);Papp, K. (author);Strober, B. (author);Thaçi, D. (author);Colston, E. (author);Throup, J. (author);Kundu, S. (author);Banerjee, S. (author);Blauvelt, A. (author)
- Publisher
- Elsevier BV
- Published
- 2021
- Field
- Medicine (Health Sciences)